AMY BUTTS: Open Payments
NPI 1184629404 · WELLSBURG, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$77,341 in 189 payments from 15 companies in 2025. Trend: 2023 $44,580 · 2024 $37,626 · 2025 $77,341
Speaker / faculty: $28,697Travel & lodging: $16,637Consulting: $9,603Honoraria: $9,103Speaker / faculty: $7,588Food & beverage: $5,670
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 42 | $24,918 |
| Abbott Laboratories | 65 | $24,485 |
| Corcept Therapeutics | 44 | $22,180 |
| Xeris Pharmaceuticals, Inc. | 13 | $4,977 |
| Tandem Diabetes Care, Inc. | 4 | $188 |
| Amgen Inc. | 7 | $165 |
| Mannkind Corporation | 3 | $156 |
| Madrigal Pharmaceuticals | 2 | $56 |
| Medtronic, Inc. | 1 | $50 |
| Ascendis Pharma Endocrinology Inc | 2 | $49 |
Products named: Korlym, Ozempic, FREESTYLE LIBRE 3, GVOKE HYPOPEN, t:slim X2 Insulin Pump with Control-IQ, AFREZZA, REPATHA, REZDIFFRA.
Industry payments across WV — which companies pay providers there.
